Plasticell secures funding for red blood cell substitute development
Plasticell is advancing multiple projects through which it will develop and manufacture red blood cell substitutes for human clinical transfusion and progress preclinical trials.
Archives for April 18, 2017
DermTech: demand to strengthen pharma partnerships over next 5 years
DermTech, Inc. has announced two new collaborations with pharmaceutical companies and expects more to follow as the demand for personalized, precision medicine increases.
Aurobindo Pharma gets Form 483 from US FDA after Bachupally inspection
The US FDA completed an inspection of Aurobindo Pharma Limited’s manufacturing plant in Bachupally, Hyderabad yesterday, issuing the Indian drug firm with a Form 483 detailing six observations.
US ban for levonorgestrel supplier Qinhuangdao Zizhu raises WHO concerns
Discovery of data problems at Qinhuangdao Zizhu’s Hebei API plant indicates the firm did not follow a remediation plan agreed after a prequalification inspection in 2015 according to the WHO.
1st Stem Cell Community day in Germany
For stem cells 'the process is the product,' says Pluristem
Manufacturing tweaks have severe effects on the quality and yield of stem cells, says Pluristem which has successfully scaled-up production through a decade of process development evolution.
Partnering key to deliver next-gen drug delivery tech, say industry experts
Partnering and collaborating to advance drug delivery innovation is essential, now more than ever, say industry experts from Boehringer-Ingelheim and Merck.